Delivery Order SPE2DB20D2104-SPE2DB23FU88H
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,810.68 Firm Fixed Price Delivery Order contract is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes. The contract has an ultimate completion date of December 31, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,992.39 firm-fixed-price delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used for diabetes management. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,141.00 firm fixed-price delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract has a period of performance through November 20, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,227.47 firm fixed-price delivery order is for TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The award has an ultimate completion date of January 8, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,711.25 firm-fixed-price delivery order is for the supply of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, a medication used for diabetes management. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,354.20 firm fixed-price delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used for diabetes management. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,792.70 firm fixed-price delivery order is for TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has an ultimate completion date of February 12, 2025 and was awarded on February 11, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,594.35, is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a medication used to manage diabetes. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,871.22, is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a medication used to manage diabetes. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,230.94 contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes. The award has a firm fixed price and an ultimate completion date of November 14, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FU88HDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,338.22 delivery order contract is for the supply of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, a prescription medication used to treat diabetes. The contract has an ultimate completion date of August 16, 2023 and is a firm fixed-price agreement. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 8/15/23 |